1. Home
  2. AMPH vs PCT Comparison

AMPH vs PCT Comparison

Compare AMPH & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • PCT
  • Stock Information
  • Founded
  • AMPH 1996
  • PCT 2015
  • Country
  • AMPH United States
  • PCT United States
  • Employees
  • AMPH N/A
  • PCT N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • PCT Environmental Services
  • Sector
  • AMPH Health Care
  • PCT Utilities
  • Exchange
  • AMPH Nasdaq
  • PCT Nasdaq
  • Market Cap
  • AMPH 1.1B
  • PCT 2.5B
  • IPO Year
  • AMPH 2014
  • PCT N/A
  • Fundamental
  • Price
  • AMPH $21.29
  • PCT $15.69
  • Analyst Decision
  • AMPH Hold
  • PCT Strong Buy
  • Analyst Count
  • AMPH 5
  • PCT 4
  • Target Price
  • AMPH $38.00
  • PCT $13.00
  • AVG Volume (30 Days)
  • AMPH 497.9K
  • PCT 5.0M
  • Earning Date
  • AMPH 08-06-2025
  • PCT 08-07-2025
  • Dividend Yield
  • AMPH N/A
  • PCT N/A
  • EPS Growth
  • AMPH N/A
  • PCT N/A
  • EPS
  • AMPH 2.77
  • PCT N/A
  • Revenue
  • AMPH $730,659,000.00
  • PCT $1,580,000.00
  • Revenue This Year
  • AMPH $0.67
  • PCT $99.94
  • Revenue Next Year
  • AMPH $5.18
  • PCT N/A
  • P/E Ratio
  • AMPH $7.66
  • PCT N/A
  • Revenue Growth
  • AMPH 8.05
  • PCT N/A
  • 52 Week Low
  • AMPH $21.17
  • PCT $4.50
  • 52 Week High
  • AMPH $53.96
  • PCT $15.98
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 31.67
  • PCT 74.34
  • Support Level
  • AMPH $21.48
  • PCT $15.00
  • Resistance Level
  • AMPH $23.77
  • PCT $15.88
  • Average True Range (ATR)
  • AMPH 0.76
  • PCT 0.71
  • MACD
  • AMPH -0.15
  • PCT 0.04
  • Stochastic Oscillator
  • AMPH 16.07
  • PCT 93.06

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: